Back to Search
Start Over
PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD).
- Source :
-
Biochemical pharmacology [Biochem Pharmacol] 2022 Aug; Vol. 202, pp. 115119. Date of Electronic Publication: 2022 Jun 03. - Publication Year :
- 2022
-
Abstract
- Background: Chronic inflammation of the gastrointestinal tract is a feature of inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). Targeting inflammatory signaling represents promising strategy for IBD treatment regimens.<br />Methods: Dextran sulfate sodium (DSS)-induced colitis model was established in mice. Histopathological examinations were conducted by H&E staining and IHC staining. IL-1β, IL-10, and TNF-α were tested by ELISA kits. TargetScan was used to predict miRNAs that target PPARGC1A and luciferase activity assay was performed to validate the predicted binding.<br />Results: DSS-induced acute colitis model was successfully established in mice; photodynamic therapy (PDT) treatment partially improved DSS-induced colonic damages and cell inflammation. Microarray assays and integrative bioinformatics analysis identified PPARG coactivator 1 alpha (PPARGC1A) as a significantly differentially-expressed gene in PDT-treated IBD compared with non-treated IBD. PPARGC1A expression was downregulated in IBD clinical samples, DSS-induced colitis mice colons, and DSS-stimulated colonic epithelial cells, whereas partially upregulated by PDT treatment in DSS-stimulated cells. Single DSS stimulation significantly promoted cellular inflammation; PDT partially attenuated, whereas sh-PPARGC1A transduction further enhanced DSS effects on cancer cell inflammation. In colitis mice, DSS decreased PPRA-α and PPRA-γ proteins in mice colons; the in vivo effects of DSS were partially attenuated by PDT treatment, whereas amplified by sh-PPARGC1A transduction. Upstream miR-301a-3p targeted and inhibited PPARGC1A expression.<br />Conclusions: Collectively, PPARGC1A, which is downregulated in DSS-induced acute colitis and DSS-stimulated colonic epithelial cells, could be upregulated by PDT treatment. PPARGC1A knockdown could attenuate PDT therapeutic effects on DSS-induced acute colitis and DSS-stimulated colonic epithelial cells.<br /> (Copyright © 2022. Published by Elsevier Inc.)
- Subjects :
- Animals
Colon metabolism
Cytokines metabolism
Dextran Sulfate toxicity
Disease Models, Animal
Inflammation metabolism
Mice
Mice, Inbred C57BL
Colitis chemically induced
Colitis drug therapy
Colitis pathology
Inflammatory Bowel Diseases chemically induced
Inflammatory Bowel Diseases drug therapy
Inflammatory Bowel Diseases metabolism
Photochemotherapy
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2968
- Volume :
- 202
- Database :
- MEDLINE
- Journal :
- Biochemical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 35667414
- Full Text :
- https://doi.org/10.1016/j.bcp.2022.115119